Markets

Ares Management Corporation has acquired a 20% stake in Plenitude, Eni’s energy transition business, for €2 billion, valuing Plenitude at over €12 billion. The investment highlights the growing interest in energy transition companies like Plenitude, which integrates renewable energy generation, energy sales, and EV charging infrastructure across 15 countries. Plenitude aims to reach 10 GW of renewable capacity by 2028. Ares’ investment aligns with its strategy of deploying capital in sectors driven by long-term secular trends, particularly the energy transition.

E3 Lithium will host a webinar on November 5, 2025, at 9:00 AM MT, led by CEO Chris Doornbos. Updates will cover progress on Phase 1 & 2 Demonstration Facilities, recent equity financing, and E3 Lithium’s role in the North American critical minerals landscape. Governmental initiatives and upcoming milestones for the Clearwater Project in Q4 2025 and 2026 will also be discussed. A live Q&A session will follow a 45-minute presentation, with a recording available on the company’s website. E3 Lithium focuses on developing lithium resources in Alberta and Saskatchewan, emphasizing Direct Lithium Extraction technologies.

Innate Pharma SA (IPHA) will host a conference call on November 13, 2025, to discuss its Q3 2025 business progress. Key executives will present and answer questions. The call will be webcast live and available for replay on the company website. Innate Pharma focuses on developing immunotherapies, including lacutamab, IPH4502, and monalizumab. Investors will focus on clinical trial updates, cash runway, and competitive advantages. Note the presence of forward-looking statements subject to risks detailed in company filings.

Kodiak Gas Services, Inc. (NYSE: KGS) will release its third-quarter 2025 financial results on November 5, 2025. A conference call and live webcast will be held at 11:00 a.m. Eastern Time to discuss the results and provide insights into the company’s performance and outlook. As a leading contract compression services provider, Kodiak plays a critical role in natural gas infrastructure, benefiting from robust demand and increasing midstream investments. The company reminds investors of potential risks and uncertainties in forward-looking statements, as detailed in their SEC filings.

Wave Life Sciences will present preclinical data for WVE-007 (INHBE GalNAc-siRNA) at ObesityWeek, showcasing its potential to drive fat loss while preserving muscle with infrequent dosing. Preclinical studies in DIO mice demonstrated significant weight loss, reduced visceral fat, and improved insulin sensitivity. When combined with semaglutide, weight loss doubled. Early clinical data from the INLIGHT trial show dose-dependent Activin E reductions (56-85%) that were sustained through six months. WVE-007 has shown a promising safety profile.

Omdia reports record display glass revenues of JPY 270 billion in Q3 2025, up 14% year-over-year, driven by price increases and demand. Manufacturers prioritize profitability over market share, raising prices over 25% in two years and optimizing production. Chinese manufacturers are investing heavily in G8.5 glass, potentially impacting market share. Established players are diversifying into semiconductor and other high-margin applications to counter competition and secure future growth, suggesting a shift in the display glass market landscape.

Urgently (ULY) will release its Q3 2025 financial results on Wednesday, November 12, 2025, and host a conference call at 5:00 p.m. ET to discuss them. The results cover the period ending September 30, 2025. Investors can join the webcast via Urgently’s Investor Relations website or dial in at 1-877-317-6789 (USA) or 1-412-317-6789 (International). A replay will also be available on the Investor Relations website. The company aims to expand its market and enhance its tech through AI.

Hemostemix (HMTXF) closed the first tranche of a private placement, raising $461,230 by issuing 4,193,000 Units at $0.11 each. Each Unit includes a share and a warrant exercisable at $0.15. Proceeds fund working capital and VesCell marketing. Finder’s fees were paid, and certain directors participated, triggering related party considerations with MI 61-101 exemptions. The closing is subject to regulatory approval, and securities are subject to a four-month hold period. The offering introduces potential dilution from new shares and warrants.

Sprott Inc. (SII) announced a 33% increase in its Q3 2025 dividend to US$0.40 per common share, payable December 2, 2025, to shareholders of record on November 17, 2025. Currency exchange rules apply; Canadian shareholders via CDS receive CAD, while others receive USD. CDS participants can elect USD payments via their broker. The dividend is an eligible dividend for Canadian tax purposes. Analysts view this increase positively, reflecting Sprott’s strong position in precious metals and critical materials.

Penguin Solutions will showcase its HPC and AI infrastructure advancements at Supercomputing 25 (SC25) in St. Louis, November 16-21, 2025. Attendees will gain insights into manageability, scalability, and performance for advanced AI solutions. Highlights include demonstrations of Penguin’s technologies and its partnership with SK Telecom on Haein, a large-scale AI factory powered by NVIDIA Blackwell GPUs, enabling national AI strategies. Penguin Solutions aims to optimize AI workflows and accelerate time-to-insight.